Company Filing History:
6 out of 3,684 
6 out of 38 
3 out of 10,754 
Years Active: 2002-2021
Title: Laura Price: Innovator in Antibody Polypeptides
Introduction
Laura Price is a distinguished inventor based in Langhorne, Pennsylvania. She has made significant contributions to the field of biotechnology, particularly in the development of antibody polypeptides. With a total of nine patents to her name, her work focuses on innovative solutions for treating diseases related to CD40L activation.
Latest Patents
Among her latest patents, Laura has developed antibody polypeptides that specifically bind human CD40L. These antibody polypeptides are designed not to activate platelets, making them useful in treating various diseases, including graft-related and autoimmune diseases. Additionally, her patents include methods for treating immune diseases by administering these specific antibody polypeptides. The antibody polypeptides may also be domain antibodies (dAbs) comprising a single Vor Vdomain. Furthermore, the half-life of these antibody polypeptides can be enhanced by modifying them to be dual-specific reagents that can also bind human serum albumin (HSA) or other antigens.
Career Highlights
Laura Price has had a notable career, working with prominent companies in the biotechnology sector. She has been associated with Bristol-Myers Squibb Company and Domantis Limited, where she has contributed her expertise in antibody development and therapeutic applications.
Collaborations
Throughout her career, Laura has collaborated with esteemed colleagues, including Steven G. Nadler and James K. Tamura. These collaborations have further enriched her research and innovation in the field.
Conclusion
Laura Price stands out as a leading inventor in the biotechnology industry, with her innovative work on antibody polypeptides paving the way for new treatments for immune-related diseases. Her contributions continue to impact the field significantly.